Despite the availability of six FDA-approved anti-obesity medications (AOMs) for chronic weight management, current guidelines recommend waiting six months after behavioral therapy begins before adding pharmacological support
Protein shakes, bone broth, Greek yogurt, cottage cheese, and collagen peptides can all contribute to meeting this target without requiring large food volumes
GLP-1 agonist formulations contain various inactive ingredients, including preservatives, stabilisers, and solvents
Our Healthcare providers at Rivas Medical Weight Loss carefully consider these factors when prescribing GLP-1 agonists to ensure optimal efficacy and minimize potential side effects
IGF-1 LR3 may raise more concern around blood sugar changes, growth-factor activity, and improper use by beginners